These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 12542895

  • 1. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A, Young IS, Wisdom GB.
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [Abstract] [Full Text] [Related]

  • 2. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z, Mrzljak V, Turk N, Metelko Z.
    Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
    [Abstract] [Full Text] [Related]

  • 3. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E, Marchesi E, Ravetta V, Martignoni A, Finardi G, Bellomo G.
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [Abstract] [Full Text] [Related]

  • 4. Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease.
    Soto Y, Conde H, Aroche R, Brito V, Luaces P, Nasiff A, Obregón A, Vázquez López AM.
    Hum Antibodies; 2009 Jan; 18(3):109-17. PubMed ID: 19729805
    [Abstract] [Full Text] [Related]

  • 5. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA, Hadzhimitova V, Ribarov S.
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [Abstract] [Full Text] [Related]

  • 6. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z, Sesto M, Skodlar J, Ferencak G, Turk N, Stavljenić-Rukavina A.
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [Abstract] [Full Text] [Related]

  • 7. Significantly higher levels of oxidized LDL autoantibody in coronary artery disease patients.
    Liang KW, Huang JL, Kao CH, Hsueh CW, Ho HY, Lee WL, Wang KY, Huang DS, Chen YT, Ting CT.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):101-6. PubMed ID: 10677919
    [Abstract] [Full Text] [Related]

  • 8. Auto antibodies against oxidized low density lipoprotein in severe preeclampsia.
    Jain M, Sawhney H, Aggarwal N, Vashistha K, Majumdhar S.
    J Obstet Gynaecol Res; 2004 Jun; 30(3):188-92. PubMed ID: 15210040
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls.
    van de Vijver LP, Steyger R, van Poppel G, Boer JM, Kruijssen DA, Seidell JC, Princen HM.
    Atherosclerosis; 1996 May; 122(2):245-53. PubMed ID: 8769687
    [Abstract] [Full Text] [Related]

  • 10. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect.
    Johnston TP, Zhou X.
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410
    [Abstract] [Full Text] [Related]

  • 11. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [Abstract] [Full Text] [Related]

  • 12. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS.
    Nephron Clin Pract; 2008 Jul; 108(4):c298-304. PubMed ID: 18434752
    [Abstract] [Full Text] [Related]

  • 13. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
    Prasad A, Clopton P, Ayers C, Khera A, de Lemos JA, Witztum JL, Tsimikas S.
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443
    [Abstract] [Full Text] [Related]

  • 14. Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery disease.
    Ogasawara K, Mashiba S, Hashimoto H, Kojima S, Matsuno S, Takeya M, Uchida K, Yajima J.
    Clin Chim Acta; 2008 Nov; 397(1-2):42-7. PubMed ID: 18691566
    [Abstract] [Full Text] [Related]

  • 15. The complex link between oxidised low-density lipoprotein and unstable angina.
    Niccoli G, Mongiardo R, Lanza GA, Ricco A, Burzotta F, Trani C, Mazzari MA, Liuzzo G, Lombardo A, Rebuzzi AG, Holvoet P, Crea F.
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):387-91. PubMed ID: 17443110
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH.
    Circulation; 2004 Jun 29; 109(25):3164-70. PubMed ID: 15184281
    [Abstract] [Full Text] [Related]

  • 17. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
    Boullier A, Hamon M, Walters-Laporte E, Martin-Nizart F, Mackereel R, Fruchart JC, Bertrand M, Duriez P.
    Clin Chim Acta; 1995 Jun 30; 238(1):1-10. PubMed ID: 7554289
    [Abstract] [Full Text] [Related]

  • 18. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI, Atsumi T, Tinahones FJ, Gómez-Zumaquero JM, Amengual O, Khamashta MA, Hughes GR.
    Arthritis Rheum; 1999 Dec 30; 42(12):2606-11. PubMed ID: 10616007
    [Abstract] [Full Text] [Related]

  • 19. Apolipoproteins as markers and managers of coronary risk.
    Chan DC, Watts GF.
    QJM; 2006 May 30; 99(5):277-87. PubMed ID: 16504986
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME, McInerney D, Fraser A, Johnson AH, Collins PB, Owens D, Tomkin GH.
    Diabet Med; 1997 Sep 30; 14(9):741-7. PubMed ID: 9300223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.